“It is time to get over with the idea of losing mine through open innovation”

While ‘Open Innovation’ has been settled in the pharmaceutical industry, it was suggested Korean pharmaceutical companies should approach this trend more globally over ‘selfish’ open innovation.

Research Head Tae-Young Yoon at Dong-A ST mentioned what it stated above as introducing the ‘Dong-A ST’s Global R&D Strategy’ at the ‘KAIST CHIP 2018 Global Advisory Workshop’ held at Novetel Ambassado...